Insider Transactions last 24 months for BioMarin Pharmaceutical Inc.  -  NSDQ: BMRN

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Clark Ian TDirector08/01/2025AADirectCOM7,000$0.00$0.007,000
Burkhart ErinGVP, Chief Accounting Officer05/20/2025DSDirectCOM1,786$59.31$105,927.6614,173
Anderson Elizabeth MDirector05/20/2025AADirectCOM6,650$0.00$0.0034,450
Bodem Barbara W.Director05/20/2025AADirectCOM6,650$0.00$0.0013,555
Countouriotis AthenaDirector05/20/2025AADirectCOM6,650$0.00$0.0013,550
Dere Willard HDirector05/20/2025AADirectCOM6,650$0.00$0.0038,950
Enyedy Mark JDirector05/20/2025AADirectCOM6,650$0.00$0.0013,550
Ho MaykinDirector05/20/2025AADirectCOM6,650$0.00$0.0028,010
Hombach Robert J.Director05/20/2025AADirectCOM6,650$0.00$0.0041,870
Meier Richard ADirector05/20/2025AADirectCOM6,650$0.00$0.00127,426
Walbert Timothy PDirector05/20/2025AADirectCOM6,650$0.00$0.009,780
Hubbard CristinEVP, Chief Commercial Officer05/20/2025DFDirectCOM2,155$59.93$129,149.1530,545
Burkhart ErinGVP, Chief Accounting Officer05/19/2025DFDirectCOM996$59.27$59,032.9215,959
Hubbard CristinEVP, Chief Commercial Officer05/02/2025DSDirectCOM273$64.92$17,723.1632,700
Hubbard CristinEVP, Chief Commercial Officer04/30/2025AADirectCOM273$54.14$14,779.4032,973
Burkhart ErinGVP, Chief Accounting Officer03/19/2025DSDirectCOM1,295$71.52$92,618.4016,955
Hardy AlexanderChief Executive Officer03/17/2025AADirectCOM44,360$0.00$0.00175,583
Mueller BrianEVP, Chief Financial Officer03/17/2025AADirectCOM16,640$0.00$0.0099,781
Guyer Charles GregEVP, Chief Technical Officer03/17/2025AADirectCOM13,310$0.00$0.0080,838
Friberg Gregory REVP, Chief R&D Officer03/17/2025AADirectCOM17,750$0.00$0.0046,810
Hubbard CristinEVP, Chief Commercial Officer03/17/2025AADirectCOM13,310$0.00$0.0032,700
Davis George EricEVP, Chief Legal Officer03/17/2025AADirectCOM12,940$0.00$0.0082,915
Burkhart ErinGVP, Chief Accounting Officer03/17/2025AADirectCOM5,970$0.00$0.0018,252
Hardy AlexanderChief Executive Officer03/14/2025DFDirectCOM2,933$69.44$203,667.52131,223
Mueller BrianEVP, Chief Financial Officer03/14/2025DFDirectCOM18,497$69.44$1,284,431.6883,141
1   2  3  4  5  6  7  Next Last  You are at page 1 of 7 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel